Representative Matters

• Developed reimbursement strategies for numerous medical device, pharmaceutical, and diagnostics manufacturers positioning their new technologies for market launch and for other stages of the life cycle
• Provided strategic analysis of reimbursement landscape and healthcare regulatory developments to market investors and underwriters
• Provided regulatory counseling to medical device, pharmaceutical and biotechnology companies on Medicare and other third-party payor coverage and payment issues
• Assisted medical device, pharmaceutical, and vaccine manufacturers with successful applications for new and revised billing codes
• Assisted medical technology companies with obtaining Medicare coverage for new and existing technologies
• Assisted numerous Medicare providers and suppliers, such as major academic centers, national device companies and pharmacies, with preparation of responses to audit requests from the Office of Inspector General and Medicare administrative contractors
• Successfully represented manufacturers and providers before administrative adjudicators, resulting in the substantial reductions of Medicare overpayment liability and reversals of claims and cost report denials
• Led teams of healthcare attorneys, consultants, and support staff to conduct healthcare diligence for corporate transactions and to prepare healthcare-related disclosures for securities filings